{"id":531219,"date":"2021-02-22T17:42:01","date_gmt":"2021-02-22T17:42:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=531219"},"modified":"2021-02-22T17:42:01","modified_gmt":"2021-02-22T17:42:01","slug":"reactive-arthritis-market-size-epidemiology-leading-companies-drugs-and-competitive-analysis-by-delveinsight","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/reactive-arthritis-market-size-epidemiology-leading-companies-drugs-and-competitive-analysis-by-delveinsight_531219.html","title":{"rendered":"Reactive Arthritis Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1613967514.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Reactive Arthritis Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight\" src=\"https:\/\/www.abnewswire.com\/uploads\/1613967514.jpeg\" alt=\"Reactive Arthritis Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\">\n<div>Reactive Arthritis Market<\/div>\n<\/div>\n<\/div>\n<p style=\"text-align: justify;\">(Albany, US) DelveInsight has launched a new report on &#8220;<strong>Reactive Arthritis Market Insights, Epidemiology, and Market Forecast-2030&#8243;.<\/strong><\/p>\n<p style=\"text-align: justify;\">DelveInsight&#8217;s &#8220;<strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/reactive-arthritis-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Reactive Arthritis Market<\/a> Insights, Epidemiology, and Market Forecast-2030&#8243;<\/strong>&nbsp;report delivers an in-depth understanding of the Reactive Arthritis, historical and forecasted epidemiology as well as the Reactive Arthritis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Some of Reactive Arthritis Companies Covered:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Amgen Inc.<\/li>\n<li>AbbVie Inc.<\/li>\n<li>Novartis AG<\/li>\n<li>Teva Pharmaceutical Industries Ltd.<\/li>\n<li>Velcura Therapeutics, Inc.<\/li>\n<li>Pfizer, Inc.<\/li>\n<li>And Many Others<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Request for Free Sample Report<\/strong><a rel=\"nofollow\" href=\"file:\/\/\/C:\/Users\/DELVE\/Desktop\/ABNewswire\/Press%20Releases\/:%20https:\/www.delveinsight.com\/sample-request\/reactive-arthritis-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">: https:\/\/www.delveinsight.com\/sample-request\/reactive-arthritis-market<\/a><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Some of Reactive Arthritis Facts:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Reactive arthritis is relatively rare, and the incidence in population-based studies is reported to be 0.6 to 27 per 100,000.<\/li>\n<li>The condition occurs worldwide, predominantly affects young adults in the 20&ndash;40 age group<\/li>\n<li>Affects men more so than women<\/li>\n<li>The incidence in Europe is estimated at 30\/100&thinsp;000.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Request for Free Sample Report<\/strong><a rel=\"nofollow\" href=\"file:\/\/\/C:\/Users\/DELVE\/Desktop\/ABNewswire\/Press%20Releases\/:%20https:\/www.delveinsight.com\/sample-request\/reactive-arthritis-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">: https:\/\/www.delveinsight.com\/sample-request\/reactive-arthritis-market<\/a><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Scope of Reactive Arthritis Report:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>The report covers the descriptive overview of Reactive Arthritis, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies<\/li>\n<li>Comprehensive insight has been provided into the Reactive Arthritis epidemiology and treatment in the 7MM<\/li>\n<li>Additionally, an all-inclusive account of both the current and emerging therapies for Reactive Arthritis are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape<\/li>\n<li>A detailed review of Reactive Arthritis market; historical and forecasted is included in the report, covering drug outreach in the 7MM<\/li>\n<li>The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Reactive Arthritis market<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/reactive-arthritis-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Reactive arthritis<\/a><\/strong> is joint pain and swelling triggered by an infection in another part of your body &mdash; most often your intestines, genitals or urinary tract. Reactive arthritis usually targets your knees and the joints of your ankles and feet. Inflammation also can affect your eyes, skin and urethra. Previously, reactive arthritis was sometimes called Reiter&#8217;s syndrome, which was characterized by eye, urethra and joint inflammation.<\/p>\n<p style=\"text-align: justify;\"><strong>Reactive arthritis Symptoms:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li><strong>Pain and stiffness.<\/strong>&nbsp;The joint pain associated with reactive arthritis most commonly occurs in your knees, ankles and feet. You also might have pain in your heels, low back or buttocks.<\/li>\n<li><strong>Eye inflammation.<\/strong>&nbsp;Many people who have reactive arthritis also develop eye inflammation (conjunctivitis).<\/li>\n<li><strong>Urinary problems.<\/strong>&nbsp;Increased frequency and discomfort during urination may occur, as can inflammation of the prostate gland or cervix.<\/li>\n<li><strong>Inflammation of soft tissue where it enters bone (enthesitis).<\/strong>&nbsp;This might include muscles, tendons and ligaments.<\/li>\n<li><strong>Swollen toes or fingers.<\/strong>&nbsp;In some cases, your toes or fingers might become so swollen that they resemble sausages.<\/li>\n<li><strong>Skin problems.<\/strong>&nbsp;Reactive arthritis can affect your skin a variety of ways, including a rash on your soles and palms and mouth sores.<\/li>\n<li><strong>Low back pain.<\/strong>&nbsp;The pain tends to be worse at night or in the morning.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Request for list of Drugs covered in <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/reactive-arthritis-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Reactive Arthritis Market Report<\/a>.<\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Table of Contents:<\/strong><\/p>\n<p style=\"text-align: justify;\">1. Key Insights<\/p>\n<p style=\"text-align: justify;\">2. Executive Summary of Reactive Arthritis<\/p>\n<p style=\"text-align: justify;\">3. Competitive Intelligence Analysis for Reactive Arthritis<\/p>\n<p style=\"text-align: justify;\">4. Reactive Arthritis: Market Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">5. Reactive Arthritis: Disease Background and Overview<\/p>\n<p style=\"text-align: justify;\">6. Patient Journey<\/p>\n<p style=\"text-align: justify;\">7. Reactive Arthritis Epidemiology and Patient Population<\/p>\n<p style=\"text-align: justify;\">8. Treatment Algorithm, Current Treatment, and Medical Practices<\/p>\n<p style=\"text-align: justify;\">9. Unmet Needs<\/p>\n<p style=\"text-align: justify;\">10. Key Endpoints of Reactive Arthritis Treatment<\/p>\n<p style=\"text-align: justify;\">11. Marketed Products<\/p>\n<p style=\"text-align: justify;\">12. Emerging Therapies<\/p>\n<p style=\"text-align: justify;\">13. Reactive Arthritis: Seven Major Market Analysis<\/p>\n<p style=\"text-align: justify;\">14. Attribute analysis<\/p>\n<p style=\"text-align: justify;\">15. 7MM: Market Outlook<\/p>\n<p style=\"text-align: justify;\">16. Access and Reimbursement Overview of Reactive Arthritis<\/p>\n<p style=\"text-align: justify;\">17. KOL Views<\/p>\n<p style=\"text-align: justify;\">18. Market Drivers<\/p>\n<p style=\"text-align: justify;\">19. Market Barriers<\/p>\n<p style=\"text-align: justify;\">20. Appendix<\/p>\n<p style=\"text-align: justify;\">21. DelveInsight Capabilities<\/p>\n<p style=\"text-align: justify;\">22. Disclaimer<\/p>\n<p style=\"text-align: justify;\">23. About DelveInsight<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Request for Free Sample Report<\/strong>: https:\/\/www.delveinsight.com\/sample-request\/reactive-arthritis-market<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56434.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Ankit Nigam<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=reactive-arthritis-market-size-epidemiology-leading-companies-drugs-and-competitive-analysis-by-delveinsight\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +19193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Albany<br \/><strong>State:<\/strong> New York<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/report-store\/reactive-arthritis-market\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/report-store\/reactive-arthritis-market<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/report-store\/reactive-arthritis-market\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=reactive-arthritis-market-size-epidemiology-leading-companies-drugs-and-competitive-analysis-by-delveinsight\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Reactive Arthritis Market (Albany, US) DelveInsight has launched a new report on &#8220;Reactive Arthritis Market Insights, Epidemiology, and Market Forecast-2030&#8243;. DelveInsight&#8217;s &#8220;Reactive Arthritis Market Insights, Epidemiology, and Market Forecast-2030&#8243;&nbsp;report delivers an in-depth understanding of the Reactive Arthritis, historical and forecasted &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/reactive-arthritis-market-size-epidemiology-leading-companies-drugs-and-competitive-analysis-by-delveinsight_531219.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,417,406,423],"tags":[],"class_list":["post-531219","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Marketing-Sales","category-Pharmaceuticals-Biotech","category-Professional-Services"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/531219","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=531219"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/531219\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=531219"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=531219"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=531219"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}